Fennec Pharmaceuticals, Inc. (FENC)
6.79
+0.49
(+7.78%)
USD |
NASDAQ |
Apr 17, 16:00
6.80
+0.01
(+0.15%)
After-Hours: 20:00
Fennec Pharmaceuticals Shareholders Equity (Quarterly) : 35.47M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 99.01M |
| Gossamer Bio, Inc. | -122.76M |
| REGENXBIO, Inc. | 102.73M |
| Zymeworks, Inc. | 268.50M |
| Apellis Pharmaceuticals, Inc. | 370.15M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 70.58M |
| Total Liabilities (Quarterly) | 35.10M |
| Current Ratio | 6.374 |
| Net Debt Paydown Yield | 2.26% |